NEW YORK, Oct. 10 – Microarray technology developer Nanogen said on Wednesday it had received a three-year, $1.5 million grant from the US Army to develop devices to detect biological warfare and infectious disease agents in human blood samples.

Nanogen’s shares rose $2.88, or 52 percent, at $8.47 in afternoon trading on the Nasdaq following the news. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Associated Press reports that gene-edited food may soon be for sale.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.